An extracranial medical device for photobiomodulation
Extra-cranial infrared photoillumination offers hope for Alzheimer's disease
It is a flexible support system that fits an adult's head. It integrates an embedded battery and about sixty infrared LEDs emitting at 810 nm, whose illumination sequences can be programmed in terms of duration and frequency.
It complies with the specifications of the IEC 60601 standard and can be used for clinical trials to evaluate the impact of extra-cranial infrared illumination for neurodegenerative pathologies, including Alzheimer's disease.
The trials are performed in a medical setting. The fact that the system does not require an external power supply strongly limits the discomfort for patients, both day and night.
What's new?
- The system complies with IEC 60601 standard specifications and is currently being validated for integration into clinical trials
- Developed in collaboration with hospital care teams to ensure proper daily use in trials
- Flexible mounting system with an autonomous power supply, minimizing patient discomfort
- Infrared LEDs positioned at a certain distance from the skin to prevent overheating
|
What's next?
- In 2023, a one-year clinical trial (Grenoble University Hospital, Clinatec
Endowment Fund) with 60 healthy subjects will be launched at Clinatec.
It will provide a database to calibrate the protocol for subsequent clinical
trials on patients with the disease.
- A clinical trial project for patients with Lewy body disease is being prepared
with the Strasbourg University Hospital.
- The flexible device can be adapted to other parts of the body, such as the
torso. Discussions are underway with cardiologists at the University Hospital
of Grenoble to evaluate possible healing benefits following a heart attack.
|